News

An abnormal protein in the brain may play an important role in the onset of Alzheimer’s disease, a group of scientists at the Mayo Clinic discovered. Although they still haven’t figured out whether this protein, called TAR DNA binding protein of 43kDa (TDP-43), is a cause of Alzheimer’s disease…

A drug prescribed for the treatment of arthritis is able to slow the progression of Alzheimer’s, according a study performed by researchers at the University of Southampton in the United Kingdom. Etanercept was administrated to patients with mild to moderate disease, and within a six-month period, the scientists verified that the…

As a result of new research conducted at the Mayo Clinic, patients with Alzheimer’s may all commonly share a newly discovered protein called TDP-43 as a potential cause for their disease, in addition to the well-known amyloid and tau proteins. Dr. Keith Josephs at the Mayo Clinic was the lead expert…